MTHFR polymorphisms have been found to be associated with both SS and SS non-MALT NHL development in association with methylation alterations, implying genetic and epigenetic abnormalities as common pathogenetic pathways in both benign autoimmunity and malignant transformation (Fragioudaki et al., in preparation). Here, MTHFR is linked to synovial sarcoma.